2022
DOI: 10.1111/ced.15257
|View full text |Cite
|
Sign up to set email alerts
|

Purple–brown coalescing macules on the mandibular area of the face

Abstract: A 71-year-old white man with Fitzpatrick skin phototype III presented with a 1-year history of asymptomatic pigmented macules on his face. His medical history was unremarkable. Physical examination revealed violaceous-brown coalescing reticulated macules, which were more prominent on both mandibular regions and very faint over the cheeks, with slight lamellar peeling and without infiltration (Fig. 1a). There were no changes in other skin areas, or in the hair, nails or oral mucosa. Routine laboratory tests wer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 5 publications
(20 reference statements)
0
1
0
Order By: Relevance
“…Selective inflammation of AK during chemotherapy is possibly a consequence of direct cytotoxicity of an active compound on atypical keratinocytes that accumulate ultraviolet-induced damage of deoxyribonucleic acid, but the exact mechanism of how different chemotherapeutics achieve this effect seems to be drug-dependent [ 13 ]. Alternative explanations of skin lesions (i.e., subacute lupus erythematosus, actinic lichen planus, cutaneous vasculitis, hypersensitivity drug reactions, drug-induced photosensitivity reactions, and photocontact dermatitis) were in both patients excluded on the basis of a history, typical clinical features of AK, and in the first case with the additional characteristic presence of atypical keratinocytes on histological examination [ 14 , 15 , 16 , 17 , 18 , 19 , 20 ].…”
Section: Discussionmentioning
confidence: 99%
“…Selective inflammation of AK during chemotherapy is possibly a consequence of direct cytotoxicity of an active compound on atypical keratinocytes that accumulate ultraviolet-induced damage of deoxyribonucleic acid, but the exact mechanism of how different chemotherapeutics achieve this effect seems to be drug-dependent [ 13 ]. Alternative explanations of skin lesions (i.e., subacute lupus erythematosus, actinic lichen planus, cutaneous vasculitis, hypersensitivity drug reactions, drug-induced photosensitivity reactions, and photocontact dermatitis) were in both patients excluded on the basis of a history, typical clinical features of AK, and in the first case with the additional characteristic presence of atypical keratinocytes on histological examination [ 14 , 15 , 16 , 17 , 18 , 19 , 20 ].…”
Section: Discussionmentioning
confidence: 99%